Near fatal bronchospasm and bradycardia after carbetocin administration

Orlando Rubén Pérez‐Nieto(Hospital Juárez de México), Luis A. Gorordo-Delsol(Hospital Juárez de México), Iván Mauricio Lima-Lucero(Hospital Juárez de México), Jorge Alberto Castañón-González(Hospital Juárez de México)

Medicina Intensiva

May 30, 2017

10.1016/j.medin.2017.04.005

Cited by 4

Related Papers

Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017

|JAMA|2020|1k

World Sepsis Day: a global agenda to target a leading cause of morbidity and mortality

|American Journal of Physiology-Lung Cellular and Molecular Physiology|2020|70

Clinical characteristics, systemic complications, and in-hospital outcomes for patients with COVID-19 in Latin America. LIVEN-Covid-19 study: A prospective, multicenter, multinational, cohort study

|PLoS ONE|2022|36

Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study

|Scientific Reports|2023|28

Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic?

|Intensive Care Medicine|2021|27